interesting proposition, $7 per share gives a market cap of about $1.8B.
Based on the LOM plan they have 9 years at 110k oz average production at say US $700 margin which gives about A$110M margin less say A$15M corporate for an annual profit of A$95M for 9 years ignoring any finance costs, non-sustaining capex, exploration, etc.
To say the above is worth A$1.8B is drawing a pretty long bow & including an awful lot of blue sky.
I would love to see it happen but would be interested in seeing some justification for your $7 value or is it just a fanciful/hopeful figure you have plucked from your nether regions in an attempt to create irrational exuberance?
- Forums
- ASX - By Stock
- KCN
- shareholder review: KCN 2023 in a nutshell
shareholder review: KCN 2023 in a nutshell, page-28
Featured News
Add KCN (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.21 |
Change
-0.035(2.81%) |
Mkt cap ! $311.8M |
Open | High | Low | Value | Volume |
$1.25 | $1.27 | $1.21 | $9.496M | 7.813M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 158372 | $1.21 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.23 | 442307 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 150372 | 1.210 |
2 | 20250 | 1.205 |
8 | 88600 | 1.200 |
1 | 20000 | 1.195 |
3 | 27090 | 1.190 |
Price($) | Vol. | No. |
---|---|---|
1.225 | 442307 | 2 |
1.230 | 373703 | 1 |
1.250 | 19078 | 3 |
1.255 | 67590 | 2 |
1.270 | 22801 | 2 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
KCN (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online